Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan-Feb;65(1):55-81.
doi: 10.3322/caac.21253. Epub 2014 Nov 19.

Recent progress in the treatment and prevention of cancer-related lymphedema

Simona F Shaitelman  1 , Kate D Cromwell, John C Rasmussen, Nicole L Stout, Jane M Armer, Bonnie B Lasinski, Janice N Cormier
Affiliations
Review

Recent progress in the treatment and prevention of cancer-related lymphedema

Simona F Shaitelman et al. CA Cancer J Clin. 2015 Jan-Feb.

Erratum in

  • CA Cancer J Clin. 2015 May-Jun;65(3):252

Abstract

This article provides an overview of the recent developments in the diagnosis, treatment, and prevention of cancer-related lymphedema. Lymphedema incidence by tumor site is evaluated. Measurement techniques and trends in patient education and treatment are also summarized to include current trends in therapeutic and surgical treatment options as well as longer-term management. Finally, an overview of the policies related to insurance coverage and reimbursement will give the clinician an overview of important trends in the diagnosis, treatment, and management of cancer-related lymphedema.

Keywords: diagnosis; lymphedema; morbidities; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Water displacement technique for the measurement of limb volume
Figure 2
Figure 2. Circumference measurements of the forearm for quantification of upper extremity lymphedema
Figure 3
Figure 3. Perometry measurement of the upper extremity
Figure 4
Figure 4. NIRF Imaging of healthy and affected limb
See this image and copyright information in PMC

References

    1. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59:8–24. - PubMed
    1. Beckjord EB, Reynolds KA, van Londen G, et al. Population-Level Trends in Post-Treatment Cancer Survivors' Concerns and Associated Receipt of Care: Results from the 2006 and 2010 LIVESTRONG Surveys. Journal of psychosocial oncology. 2013:125–151. - PMC - PubMed
    1. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579. - PubMed
    1. Armer JM, Henggeler MH, Brooks CW, Zagar EA, Homan S, Stewart BR. The Health Deviation of Post-Breast Cancer Lymphedema: Symptom Assessment and Impact on Self-Care Agency. Self Care Depend Care Nurs. 2008;16:14–21. - PMC - PubMed
    1. Carter J, Raviv L, Appollo K, Baser RE, Iasonos A, Barakat RR. A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors. Gynecol Oncol. 2010;117:317–323. - PMC - PubMed

Publication types